Test Price
2,800 AED✅ Home Collection Available
GNPTAB Gene Mucolipidosis Type III Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- ✔Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited NGS processing.
- ✔Premium Logistics: Hospital-Grade Home Collection with ISO Certified Cold-Chain Transport (8 AM–11 PM daily). VIP Mobile Phlebotomy available.
- ✔Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-certified genetic counselors.
- ✔Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This advanced NGS panel sequences the entire coding region of the GNPTAB gene to detect pathogenic variants responsible for Mucolipidosis Type III (pseudo‑Hurler polydystrophy), a rare autosomal recessive lysosomal storage disorder. Early molecular diagnosis enables precise clinical management, carrier detection, and informed family planning.
| Feature | Our Test (GNPTAB NGS) | Closest Alternative (Single‑Gene Sanger) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq) | Sanger sequencing of selected exons |
| Coverage | 100% coding region + splice sites | Partial coverage; may miss deep intronic variants |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Diagnostic Sensitivity | >99.9% | ~85% |
| Price (AED) | 2800 | 3100–3500 |
| Genetic Counselling | Included (pre‑ & post‑test) | Often not included |
Physician Insight & Safety Protocols
“Interpretation of GNPTAB variants requires integration with clinical phenotype, enzyme levels, and family history. A negative NGS result does not exclude all mucolipidosis type III subtypes; consider complementation with biochemical assays. Always involve a metabolic genetics specialist before therapeutic adjustments.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠ Do not discontinue prescribed medication without consulting your doctor. This genetic test is for diagnostic purposes only and does not replace ongoing clinical management.
Exclusion Criteria & ER Red Flags
- Patients currently experiencing a metabolic crisis (severe vomiting, lethargy, coma).
- Individuals unable to provide informed consent; minors require legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Acute signs of decompensation — seizures, hypoglycemia, unresponsiveness — require emergency care, not elective genetic testing.
Patient FAQ & Clinical Guidance
1. Who should consider this GNPTAB genetic test?
The GNPTAB Genetic Test provides definitive molecular diagnosis for mucolipidosis type III by detecting pathogenic GNPTAB gene variants. It is intended for individuals with clinical signs (coarse facies, joint stiffness, developmental delay), a positive family history, or carrier screening in high‑risk ethnic groups.
2. How is the sample collected and is it painful?
A simple blood draw or buccal swab is collected by a certified phlebotomist during home collection, and DNA is extracted for NGS analysis with minimal discomfort. Alternatively, a few drops of blood on an FTA card can be used, which is virtually painless and ideal for infants.
3. When will I receive results and what does a positive result mean?
A positive GNPTAB result confirms the genetic cause of mucolipidosis type III, enabling targeted management and genetic counseling. Reports are delivered in 3–4 weeks through a secure portal, and our team provides a tele‑consultation to explain findings and next steps.
UAE Regulatory & Data Privacy Adherence
This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, and Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE is licensed by the Dubai Health Authority (DHA Facility License: 1143) and accredited under ISO 9001:2015.
Clinical & Logistical Metadata
| Test Name | GNPTAB Gene Mucolipidosis Type III Genetic Test |
| Price (AED) | 2800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Blood or Buccal Swab |
| Methodology Used | Next‑Generation Sequencing (NGS) |
| ICD‑10‑CM Code | E77.0 |
| LOINC Code | 95456-3 |
| DHA Facility License & Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians